A Inkeri Lokki Mikko Haapio Jenni Heikkinen-Eloranta
10.3389/fimmu.2020.00548
Front Immunol
2020 Apr 3;11:548.
hellp ahus case report eculizumab preeclampsia thrombotic microangiopathy
CC BY
https://pubmed.ncbi.nlm.nih.gov/32308654/
Antibodies, Monoclonal, Humanized / therapeutic use Atypical Hemolytic Uremic Syndrome / drug therapy Complement Inactivating Agents / therapeutic use HELLP Syndrome / drug therapy Pre-Eclampsia
Antibodies, Monoclonal, Humanized / therapeutic use Atypical Hemolytic Uremic Syndrome / drug therapy Complement Inactivating Agents / therapeutic use HELLP Syndrome / drug therapy Pre-Eclampsia Case Reports Adult Atypical Hemolytic Uremic Syndrome / etiology Female HELLP Syndrome / etiology Humans Postpartum Period Pregnancy Antibodies, Monoclonal, Humanized Complement Inactivating Agents eculizumab
PMC7145984
32308654
Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS-Case Report
2020